Counselling Needs in Atopic Dermatitis: Perspectives on Pregnancy and Treatment

Atopic dermatitis (AD) is a common inflammatory skin disease affecting 5-8% of adults, with many being of reproductive age and potentially experiencing AD- and treatment-related challenges during family planning and pregnancy (FPP). This study examined whether patients with AD receive FPP-related information from their dermatologist and their concerns about pregnancy and breastfeeding. A cross-sectional questionnaire study was conducted among 18-45-year-old patients with AD treated at dermatology departments in university hospitals or private dermatology clinics in Denmark, all undergoing either topical or systemic treatment. A total of 121 patients participated in the study. The most pronounced concern was the heritable nature of AD (88.4%), followed by concerns about the teratogenicity of their treatments (29.8%). Additionally, 37.1% of women expressed concern about their ability to breastfeed. One-third of patients with AD had discussed FPP with their dermatologists prior to pregnancy, and 15% reported having fewer biological children than they desired due to their disease. Adult patients with AD have significant unmet informational needs regarding FPP. Addressing these concerns at appropriate stages in their lives, potentially through structured communication, could provide patients with better opportunities to address their concerns and plan their family life based on comprehensive and accurate information.

Authors

Institutions

Publication Details

Journal
Acta Dermato Venereologica
Published
2025-03-07
DOI
https://doi.org/10.2340/actadv.v105.42544
Citations
1
Primary Topic
Dermatology and Skin Diseases
Type
article
Field-Weighted Citation Impact
2.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Counselling Needs in Atopic Dermatitis: Perspectives on Pregnancy and Treatment

Jacob Pontoppidan Thyssen, Simon Francis Thomsen, Mette Sondergaard Deleuran, Catalina Hartmann Skovsgård et al.
1 citations
Acta Dermato Venereologica
Dermatology and Skin Diseases
2.00
article

Counselling Needs in Atopic Dermatitis: Perspectives on Pregnancy and Treatment

Jacob Pontoppidan Thyssen, Simon Francis Thomsen, Mette Sondergaard Deleuran, Catalina Hartmann Skovsgård, Christian Vestergaard, Anne Sofie Frølunde
article en
1 citations

Abstract

Atopic dermatitis (AD) is a common inflammatory skin disease affecting 5-8% of adults, with many being of reproductive age and potentially experiencing AD- and treatment-related challenges during family planning and pregnancy (FPP). This study examined whether patients with AD receive FPP-related information from their dermatologist and their concerns about pregnancy and breastfeeding. A cross-sectional questionnaire study was conducted among 18-45-year-old patients with AD treated at dermatology departments in university hospitals or private dermatology clinics in Denmark, all undergoing either topical or systemic treatment. A total of 121 patients participated in the study. The most pronounced concern was the heritable nature of AD (88.4%), followed by concerns about the teratogenicity of their treatments (29.8%). Additionally, 37.1% of women expressed concern about their ability to breastfeed. One-third of patients with AD had discussed FPP with their dermatologists prior to pregnancy, and 15% reported having fewer biological children than they desired due to their disease. Adult patients with AD have significant unmet informational needs regarding FPP. Addressing these concerns at appropriate stages in their lives, potentially through structured communication, could provide patients with better opportunities to address their concerns and plan their family life based on comprehensive and accurate information.

Acta Dermato VenereologicaVol. 105
Bispebjerg Hospital (DK), Aarhus University Hospital (DK)
Eli Lilly and Company, Pfizer, AstraZeneca, Sanofi, Regeneron Pharmaceuticals, Savvaerksejer Jeppe Juhl og Hustru Ovita Juhls Mindelegat, Celldex Therapeutics, Les Laboratories Pierre Fabre, Incyte, Coloplast, Lundbeckfonden, Novo Nordisk, Galderma, Servier, LEO Fondet, H. Lundbeck A/S, Symphogen, LEO Pharma, Sanofi Genzyme, Cilag
Good health and well-being
Openalex Percentile: Top 17%
Dermatology and Skin Diseases
2.00
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.